NovoSight cfDNA
Sensitive Detection. Intelligent Scaling.
NovoSight™ cfDNA combines high-sensitivity donor-derived cell-free DNA (dd-cfDNA) analysis with a scalable next-generation sequencing (NGS) workflow and automated bioinformatics.
Designed to accommodate varying sample volumes, the assay incorporates more than 100 genomic markers to support accurate and precise donor-derived cfDNA quantification while streamlining laboratory workflows.
For Research Use Only. Not for use in diagnostic procedures.
Key Benefits
-
Accurate and precise quantification of donor-derived cfDNA
-
More than 100 genomic markers to support analytical confidence
-
Well-suited for multi-organ and retransplant research cases
-
Rapid turnaround from sample to report
-
Automated data analysis to minimize hands-on review time
-
Flexible workflow to accommodate varying sample volumes
NovoSight Chimerism
Highly Accurate. Highly Informative.
NovoSight™ Chimerism combines dense single nucleotide polymorphism (SNP) interrogation, sophisticated computational analysis, and a simple, scalable NGS workflow to support laboratories of all sizes.
Featuring more than 100 genomic markers, the assay supports accurate donor/recipient quantification and sensitive detection of mixed chimerism. Its genomic coverage includes all chromosomes, including X and Y, with dense coverage of chromosome 6p for HLA loss of heterozygosity (HLA-LOH) screening.
For Research Use Only. Not for use in diagnostic procedures.
Key Benefits
-
Highly accurate and precise donor/recipient quantification
-
Sensitive detection of mixed chimerism
-
More than 100 genomic markers for highly informative analysis
-
Coverage of all chromosomes, including X and Y
-
Dense chromosome 6p coverage for HLA-LOH screening
-
Simple, scalable NGS workflow
Heirloom Diagnostics' Transplant Surveyor Software
Sophisticated Analytics. Operational Efficiency.
Transplant Surveyor™ is an advanced analysis platform that combines proprietary algorithms with an intuitive interface to transform complex NGS data into clear results that simplify review and sign-off.
Designed to support a line of innovative assays, the platform provides analytical tools for challenging genetic relationships and complex transplant scenarios. Automated quality metrics and longitudinal tracking capabilities help streamline data interpretation and laboratory workflows.
Transplant Surveyor is a trademark of Heirloom Diagnostics, LLC.
Key Benefits
Advanced Analytics
-
Proprietary analysis algorithms
-
Automated quality metrics
-
Support for challenging genetic relationships and complex transplant scenarios
-
Longitudinal tracking
Operational Efficiency
-
Reduced manual interpretation
-
Simplified data review
Early Access Program
Interested in Evaluating Emerging Technologies?
The De Facto Diagnostics Early Access Program offers participating laboratories an opportunity to evaluate NovoSight™ cfDNA and NovoSight™ Chimerism in their laboratory environments.
Through the program, De Facto Diagnostics and Heirloom Diagnostics will gather information about product performance across different laboratory settings to support ongoing technology development.
Participation is limited to ensure appropriate time and resources are available to manage the program.